Polyclonality of BRAF mutations in acquired melanocytic nevi.

Melanocytic nevi are thought to be senescent clones of melanocytes that have acquired an oncogenic BRAF mutation. BRAF mutation is considered to be a crucial step in the initiation of melanocyte transformation. However, using immunomagnetic separation or laser-capture microdissection, we examined BRAF mutations in sets of approximately 50 single cells isolated from acquired melanocytic nevi from 13 patients and found a substantial number of nevus cells that contained wild-type BRAF mixed with nevus cells that contained BRAF(V600E). Furthermore, we simultaneously amplified BRAF exon 15 and a neighboring single nucleotide polymorphism (SNP), rs7801086, from nevus cell samples obtained from four patients who were heterozygous for this SNP. Subcloning and sequencing of the polymerase chain reaction products showed that both SNP alleles harbored the BRAF(V600E) mutation, indicating that the same BRAF(V600E) mutation originated from different cells. The polyclonality of BRAF mutations in acquired melanocytic nevi suggests that mutation of BRAF may not be an initial event in melanocyte transformation.

[1]  D. Morton,et al.  Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors , 2008, Molecular Cancer Therapeutics.

[2]  D. Peeper,et al.  BRAFE600 in benign and malignant human tumours , 2008, Oncogene.

[3]  T. Saida,et al.  High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. , 2006, The Journal of investigative dermatology.

[4]  R. Marais,et al.  Cellular senescence in naevi and immortalisation in melanoma: a role for p16? , 2006, British Journal of Cancer.

[5]  Y. Kawakami,et al.  The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells , 2006, The Journal of experimental medicine.

[6]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[7]  D. Barford,et al.  Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.

[8]  S. Ferrone,et al.  Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance. , 2004, Critical reviews in immunology.

[9]  J. Harper,et al.  Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosis. , 2003, Molecular human reproduction.

[10]  S. Lakhani,et al.  X-inactivation patch size in human female tissue confounds the assessment of tumor clonality , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Meltzer,et al.  High frequency of BRAF mutations in nevi , 2003, Nature Genetics.

[12]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[13]  A. Elefanty,et al.  Human acquired naevi are clonal , 1998, Melanoma research.

[14]  F. Amicarelli,et al.  Cyto-genotoxic species leakage within human melanoma melanosomes. Molecular-morphological correlations. , 1994, Biochemistry and molecular biology international.

[15]  A. Ackerman,et al.  Naming acquired melanocytic nevi. Unna's, Miescher's, Spitz's Clark's. , 1990, The American Journal of dermatopathology.